Results 211 to 220 of about 242,735 (262)

EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol. [PDF]

ESMO Gastrointest Oncol
Petrillo A, Oudijk L, Sundar R, Daumer C, Casas J, D'Haese D, Mauer M, van Grieken N, Smyth EC, Moehler M.   +9 more
europepmc   +1 more source

Stomach Cancer Prediction Model (SCoPM): An approach to risk stratification in a diverse U.S. population. [PDF]

PLoS One
Wu BU, Dong EY, Chen Q, Luong TQ, Lustigova E, Jeon CY, Chen W.   +6 more
europepmc   +1 more source

The Combination of Afatinib With Dasatinib or Miransertib Results in Synergistic Growth Inhibition of Stomach Cancer Cells. [PDF]

World J Oncol
Al-Janaby T, Nahi N, Seddon A, Bagwan I, Khelwatty S, Modjtahedi H.   +5 more
europepmc   +1 more source

Apoptotic cell death of stomach cancer lines (AGS) induced by Co-NTB complex through cellular organelles and DNA damage. [PDF]

RSC Adv
Balusamy SR, Balamurugan M, Purushothaman S, Somasundaram S, Elsadek MF, Sohn D, Almutairi SM, Mijakovic I, Rahimi S, Perumalsamy H.   +9 more
europepmc   +1 more source

RETRACTION: A Meta-Analysis of the Effect of Endoscopic Submucosal Dissection Compared with Gastrectomy on the Wound Infection in Early Stomach Cancer Subjects. [PDF]

Int Wound J
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cancer of the Stomach

Archives of Surgery, 1958
It is obvious in a critical comparative survey of the literature on gastric carcinoma that there is a wide variation in the published five-year survival rates. Thus, the reported rates expressed in terms of five-year survivors range from a low of 0.7% to a high of 35%.
R N, LEHMANN, C, MORRISON, A, RUTNER, C J, KOUCKY, G S, WILSON   +4 more
openaire   +2 more sources

Cancer of the stomach

The American Journal of Surgery, 1981
Carcinoma of the stomach, although its incidence is decreasing in the United States, is still a fatal disease. The results today are actually no better than they were 30 years ago because we are still making late diagnoses. In order to improve our results in the treatment of cancer of the stomach, we must perform fiberoptic gastroscopy in individuals ...
A, Ochsner, T E, Weed, W R, Nuessle
openaire   +2 more sources

Pharmacogenomics and stomach cancer

Pharmacogenomics, 2004
In subgroups of gastric cancer patients, chemotherapy treatments carry a high risk of toxicity without any clear evidence of antitumor activity. Individualization of therapy is required to treat each patient with the optimal drug and dose. Genetic polymorphisms are the hereditary determinants for interindividual variations of drug effect and the ...
Giuseppe, Toffoli, Erika, Cecchin
openaire   +2 more sources

Nutrition and stomach cancer

Cancer Causes and Control, 1996
Epidemiologic evidence on the relation between nutrition and stomach cancer is reviewed. Stomach cancer shows a distinct international variation and dramatic worldwide decline. These descriptive features suggest that dietary factors are important in determining the risk of stomach cancer.
S, Kono, T, Hirohata
openaire   +2 more sources

Epidemiology of Stomach Cancer

2009
Despite a major decline in incidence and mortality over several decades, stomach cancer is still the fourth most common cancer and the second most common cause of cancer death in the world. There is a 10-fold variation in incidence between populations at the highest and lowest risk.
Hermann, Brenner, Dietrich, Rothenbacher, Volker, Arndt   +2 more
openaire   +2 more sources